Flora Growth Future Growth
Future criteria checks 1/6
Flora Growth is forecast to grow earnings and revenue by 155.1% and 8.2% per annum respectively while EPS is expected to grow by 157.4% per annum.
Key information
155.1%
Earnings growth rate
157.4%
EPS growth rate
| Personal Products earnings growth | 7.7% |
| Revenue growth rate | 8.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 70 | 1 | N/A | -9 | 2 |
| 12/31/2024 | 60 | -8 | N/A | -8 | 1 |
| 9/30/2024 | 64 | -18 | -5 | -5 | N/A |
| 6/30/2024 | 69 | -13 | -2 | -2 | N/A |
| 3/31/2024 | 75 | -48 | -6 | -5 | N/A |
| 12/31/2023 | 76 | -47 | -9 | -8 | N/A |
| 9/30/2023 | 69 | -50 | -9 | -8 | N/A |
| 6/30/2023 | 61 | -57 | -13 | -13 | N/A |
| 3/31/2023 | 48 | -42 | -15 | -14 | N/A |
| 12/31/2022 | 33 | -46 | -17 | -16 | N/A |
| 9/30/2022 | 28 | -48 | -20 | -17 | N/A |
| 6/30/2022 | 20 | -45 | -29 | -26 | N/A |
| 3/31/2022 | 13 | -26 | -28 | -25 | N/A |
| 12/31/2021 | 9 | -21 | -25 | -21 | N/A |
| 9/30/2021 | 4 | -15 | -24 | -22 | N/A |
| 6/30/2021 | 2 | -17 | -14 | -12 | N/A |
| 3/31/2021 | 1 | -15 | -11 | -10 | N/A |
| 12/31/2020 | 0 | -14 | -9 | -8 | N/A |
| 6/30/2020 | N/A | -4 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7301 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 7301 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 7301 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 7301's revenue (8.2% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 7301's revenue (8.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 7301's Return on Equity is forecast to be high in 3 years time